Choong Ang Vaccine Laboratories Co., Ltd. logo

Choong Ang Vaccine Laboratories Co., Ltd. (072020)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
9,360. 00
+60
+0.6452%
92.74B Market Cap
- P/E Ratio
400% Div Yield
7,971 Volume
- Eps
9,300
Previous Close
Add Transaction
Day Range
9,220 9,450
Year Range
8,560 10,350
Want to track 072020 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Choong Ang Vaccine Laboratories Co., Ltd. (072020) Statistics

Valuation metrics

Market Cap 92.74B
Enterprise value 87.09B
Trailing P/E (ttm) 12.76
Forward P/E -
PEG ratio 0.15
Price/Sales (ttm) 2.38
Price/Book (mrq) 0.81
Enterprise Value/Revenue 2.22
Enterprise Value/EBITDA 8.7

Overview

Shares outstanding 9.36M
Float 5.53M
Shares short -
% Held by insiders 0.35%
% Held by institutions 0%
Average volume (10 days) 36.2K
Average volume (90 days) 43.95K

Price summary

52-Week low 8,560
52-Week high 10,350
Beta 0.54
50-Day moving average 9,519.4
200-Day moving average 9,662.7

Dividends and splits

Forward annual dividend rate 400
Forward annual dividend yield 0.0404%
Trailing annual dividend rate 100
Trailing annual dividend yield 0.0101%
5-Year annual dividend yield 1.19%
Payout ratio 0.25
Dividend Date 3 Jan 2024
Ex-Dividend Date 27 Dec 2023
Last split factor 1:1
Last split Date 18 Jul 2018

Financials

Fiscal year

Fiscal year ends 31 Dec 2022
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.09%
Operating margin 0.19%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.04%

Income Statement

Revenue (ttm) 39.19B
Revenue per share (ttm) 4,029.22
Quarterly revenue growth (yoy) -0.01%
Gross profit (ttm) 18.66B
EBITDA 16.15B
Net income to common (ttm) 3.65B
Diluted EPS (ttm) 713
Quarterly earnings growth (yoy) -0.18%

Balance Sheet

Total cash (mrq) 18.14B
Total cash per share (mrq) 1,877.9
Total debt (mrq) 11.15B
Total Debt/Equity (mrq) 11.6
Current ratio (mrq) 3.11%
Book value per share (mrq) 11,168.66

Cash Flow

Cash flow statement 6.41B
Levered free cash flow (LFCF) -503.45M